Spinal endogenous acetylcholine contributes to the analgesic effect of systemic morphine in rats

Anesthesiology

Volumn 95, Issue 2, 2001, Pages 525-530

  Chen, Shao Rui ^a,c   Pan, Hui Lin ^b,c  

^a Department of Anesthesiology ^*  (United States)

^b Departments of Anesthesiology and Neuroscience and Anatomy   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANALGESIC AGENT; ATROPINE; MECAMYLAMINE; MORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT;

ANALGESIA; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD; WITHDRAWAL REFLEX;

EID: 0034895176     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200108000-00039     Document Type: Article

References (38)

1. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry
2. Dissociation of supraspinal and spinal actions of morphine: A quantitative evaluation
3. Differential actions of the blockade of spinal opioid, adrenergic and serotonergic receptors on the tail-flick inhibition induced by morphine microinjected into dorsal raphe and central gray in rats
4. Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons
5. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-adrenergic and cholinergic mechanism
6. Intravenous opioids stimulate norepinephrine and acetylcholine release in spinal cord dorsal horn: Systematic studies in sheep and an observation in a human
7. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems
8. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat
9. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors
10. Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition
11. Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats
12. Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors
13. Role of spinal muscarinic and nicotinic receptors in clonidine-induced nitric oxide release in a rat model of neuropathic pain
14. Evidence for the involvement of a descending cholinergic pathway in systemic morphine analgesia
15. Spinal nitric oxide mediates antinociception from intravenous morphine
16. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord
17. Epibatidine binding sites and activity in the spinal cord
18. Synergistic effect between intrathecal non-NMDA antagonist and gabapentin on allodynia induced by spinal nerve ligation in rats
19. Cholinergic spinal interneurons are responsible for clonidine-induced acetylcholine release in a chronic neuropathic pain model
20. AF64A: An active site directed irreversible inhibitor of choline acetyltransferase
21. Regulation of the synthesis of acetylcholine
22. Presynaptic effect of the aziridinium ion of acetylcholine mustard (methyl-2-acetoxyethyl-2′-chloroethylamine) on the phrenic nerve-rat diaphragm preparation
23. Influence of hemicholimium (HC-3) on morphine analgesia, tolerance, physical dependence and on brain acetylcholine
24. Reversible and irreversible inhibition of high-affinity choline transport caused by ethylcholine aziridinium ion
25. High-affinity choline transport sites: Use of [3H]hemicholinium-3 as a quantitative marker
26. Characterization of [3H]hemicholinium-3 binding associated with neuronal choline uptake sites in rat brain membranes
27. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice
28. Sodium-dependent, high affinity choline uptake
29. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo
30. The AF64a-treated mouse: Possible model for central cholinergic hypofunction
31. Analysis of muscarinic agonist-induced analgesia by the use of receptor knockout mice
32. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
33. Choline acetyltransferase-immunoreactive profiles are presynaptic to primary sensory fibers in the rat superficial dorsal horn
34. The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic neurons in the A7 catecholamine cell group
35. Enkephalin neurons that project to the A7 catecholamine cell group are located in nuclei that modulate nociception: Ventromedial medulla
36. Antinociception produced by microinjection of morphine in the rat periaqueductal gray is enhanced in the foot, but not the tail, by intrathecal injection of alpha1-adrenoceptor antagonists
37. The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry
38. Choline acetyltransferase and NADPH diaphorase are co-expressed in rat spinal cord neurons